Table I.
Association between B7-H4 expression and clinicopathological parameters.
| B7-H4 | ||||
|---|---|---|---|---|
|
|
||||
| Parameters | n | Negative (%) | Positive (%) | P-value |
| Total | 102 | 31 (30.4) | 71 (69.6) | - |
| Age (years) | ||||
| <50 | 53 | 15 (28.3) | 38 (71.7) | 0.793 |
| ≥51 | 49 | 16 (32.7) | 33 (67.3) | |
| FIGO stage | ||||
| I–IIA | 73 | 24 (32.9) | 49 (67.1) | 0.531 |
| IIB–IV | 29 | 7 (24.1) | 22 (75.9) | |
| Histological type | ||||
| Squamous | 83 | 27 (32.5) | 56 (67.5) | 0.481 |
| Adenocarcinoma | 19 | 4 (21.1) | 15 (78.9) | |
| LVSI | ||||
| Negative | 54 | 14 (25.9) | 40 (74.1) | 0.410 |
| Positive | 48 | 17 (35.4) | 31 (64.6) | |
| Lymph node | ||||
| Negative | 74 | 22 (29.7) | 52 (70.3) | 0.996 |
| Positive | 28 | 9 (32.1) | 19 (67.9) | |
FIGO, International Federation of Gynecology and Obstetrics; LVSI, lymphovascular space invasion.